Fig. 2From: Non-small cell lung cancer targeted nanoparticles with reduced side effects fabricated by flash nanoprecipitationa Size and size distribution, b DLE and DLC, and c stability of gefitinib-loaded FA-NPs and cisplatin-loaded FA-NPsBack to article page